Skip to content
RDL Network logo
6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mm — Roberto Diletti (2011) | RDL Network